LLY
749.3
-0.7%↓
JNJ
177.72
-0.2%↓
ABBV
216.91
-0.64%↓
UNH
348.68
-1.2%↓
AZN
78.03
-1.9%↓
LLY
749.3
-0.7%↓
JNJ
177.72
-0.2%↓
ABBV
216.91
-0.64%↓
UNH
348.68
-1.2%↓
AZN
78.03
-1.9%↓
LLY
749.3
-0.7%↓
JNJ
177.72
-0.2%↓
ABBV
216.91
-0.64%↓
UNH
348.68
-1.2%↓
AZN
78.03
-1.9%↓
LLY
749.3
-0.7%↓
JNJ
177.72
-0.2%↓
ABBV
216.91
-0.64%↓
UNH
348.68
-1.2%↓
AZN
78.03
-1.9%↓
LLY
749.3
-0.7%↓
JNJ
177.72
-0.2%↓
ABBV
216.91
-0.64%↓
UNH
348.68
-1.2%↓
AZN
78.03
-1.9%↓
24h
Actual
Mínimo
3.58
Máximo
3.86
Recomendaciones | Comprar |
---|---|
Estimación a 12 meses | +272.75% upside |
Próximas Ganancias | 12 nov 2025 |
---|
El rendimiento pasado no es un indicador fiable de resultados futuros.
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 14.5 USD 272.75%
Máximo 17 USD
Mínimo 12 USD
De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
2 ratings
2
Comprar
0
Mantener
0
Vender
De acuerdo con 2 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$